M. D. Anderson Cancer Center - News Releases This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Shelby Robin receives MD Anderson's highest nursing honor
Shelby Robin, pediatric nurse and former sarcoma patient at The University of Texas MD Anderson Cancer Center, is the recipient of the 2015 Brown Foundation Award for Excellence in Oncology Nursing. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - June 4, 2015 Category: Cancer & Oncology Source Type: news

MD Anderson and Exact Sciences announce partnership to develop screening and diagnostic tests for lung cancer
Exact Sciences Corp. and The University of Texas MD Anderson Cancer Center today announced an agreement to jointly develop and commercialize blood-based screening and diagnostics tests for the early detection of lung cancer. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - June 4, 2015 Category: Cancer & Oncology Source Type: news

Houston Methodist Hospital, MD Anderson Cancer Center teams perform first multi-organ transplant that includes skull and scalp
Surgical teams from Houston Methodist Hospital and The University of Texas MD Anderson Cancer Center successfully transplanted, for the first time, a scalp and skull while performing kidney and pancreas transplants. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - June 4, 2015 Category: Cancer & Oncology Source Type: news

Risks of whole brain radiation therapy added to radiosurgery outweigh benefits for patients with limited brain metastases
Whole Brain Radiation Therapy (WBRT) is associated with significantly worse cognitive function than radiosurgery, and should no longer be used in the adjuvant setting after radiosurgery to treat cancer patients with brain metastases, according to a large study led by a researcher at The University of Texas MD Anderson Cancer Center. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - May 31, 2015 Category: Cancer & Oncology Source Type: news

Study identifies possible new combination chemotherapy for patients with advanced prostate cancer
A role for combination therapy using two or more chemotherapy agents at the same time has not been well studied.  This week, however, results of a clinical trial presented at the American Society of Clinical Oncology meeting by researchers at The University of Texas MD Anderson Cancer Center may change the perspective on a role for combination chemotherapy in advanced disease. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - May 30, 2015 Category: Cancer & Oncology Source Type: news

ASCO honors Allison for achievements in cancer immunotherapy
The world's leading organization of oncologists will honor Jim Allison, Ph.D., for his pioneering research that led to a new way to treat cancer by unleashing an immune system attack rather than targeting tumors directly. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - May 29, 2015 Category: Cancer & Oncology Source Type: news

MD Anderson receives $9 million in CPRIT research funding
The University of Texas MD Anderson Cancer Center has received more than $9 million in research grants in the latest round of funding from the Cancer Prevention and Research Institute of Texas (CPRIT). The grants were announced Wednesday, May 20. Full details can be found here. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - May 21, 2015 Category: Cancer & Oncology Source Type: news

Study Finds Biomarker May Boost Ovarian Cancer Chemotherapy Response
A molecule that helps control gene expression may play a role in controlling chemotherapy resistance among patients with the most common form of ovarian cancer. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - May 20, 2015 Category: Cancer & Oncology Source Type: news

MD Anderson Making Cancer History Seminar in Austin rescheduled for June 16
Renowned oncologists from The University of Texas MD Anderson Cancer Center return to Austin June 16 for the institution's well-known Making Cancer History® educational seminar, which was rescheduled from March due to inclement weather. Doctors will discuss innovations in personalized cancer therapies, share vital cancer prevention tips and update attendees on breakthroughs made possible by the Moon Shots Program, MD Anderson's unprecedented effort to rapidly reduce cancer deaths and transform care. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - May 19, 2015 Category: Cancer & Oncology Source Type: news

Stereotactic Ablative Radiotherapy achieves better overall survival than surgery for early lung cancer
Patients with operable stage I non-small cell lung cancer (NSCLC) could achieve better overall survival rates if treated with Stereotactic Ablative Radiotherapy (SABR) rather than the current standard of care - invasive surgery - according to research from a phase III randomized international study from The University of Texas MD Anderson Cancer Center. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - May 14, 2015 Category: Cancer & Oncology Source Type: news

Protein FGL2 May Have Potential as Therapy Target for Brain Cancer
Blocking FGL2, a protein known to promote cancer, may offer a new strategy for treating brain cancer, according to a study at The University of Texas MD Anderson Cancer Center. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - May 13, 2015 Category: Cancer & Oncology Source Type: news

Tumor sequencing study highlights benefits of profiling healthy tissue as well
As the practice of genetically profiling patient tumors for clinical treatment decision making becomes more commonplace, a recent study from The University of Texas MD Anderson Cancer Center suggests that profiling normal DNA also provides an important opportunity to identify inherited mutations that could be critical for patients and their families. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - May 13, 2015 Category: Cancer & Oncology Source Type: news

Variations in liver cancer attributable to hepatitis virus variations
Significant clinical variations exist among patients with the most common type of liver cancer called hepatocellular carcinoma (HCC), depending on the viral cause of the disease -hepatitis B virus (HBV) or hepatitis C virus (HCV). These differences suggest that hepatitis status should be considered when developing treatment plans for newly diagnosed patients, according to researchers at The University of Texas MD Anderson Cancer Center. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - May 13, 2015 Category: Cancer & Oncology Source Type: news

Study May Suggest New Strategies for Myelodysplastic Syndromes Treatment
A study revealing fresh insight about chromosome "tails" called telomeres may provide scientists with a new way to look at developing treatments or even preventing a group of blood cell disorders known as myelodysplastic syndromes (MDS). (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - May 11, 2015 Category: Cancer & Oncology Source Type: news

A Conversation With a Living Legend in Washington, D.C., presented by MD Anderson, raises $5.2 million
President Bill Clinton and General Colin Powell were honored at A Conversation With a Living Legend in Washington, D.C., April 21 at the John F. Kennedy Center for the Performing Arts. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - April 27, 2015 Category: Cancer & Oncology Source Type: news